STD Rates in Connecticut

CDC surveillance data for Connecticut covering chlamydia, gonorrhea, syphilis, and HIV — with 15-year trends, state rankings, and national comparisons.

Data Year: 2023 Source: CDC STI Surveillance Population: 3,617,176
US map with Connecticut highlighted, showing a combined STD rate of 485.4 per 100,000
485.4per 100K combined
#43 / 50 states
Combined
485.4
per 100K
43rd / 50
Chlamydia
364.8
per 100K • 13,197 cases
3.8 from 2022
US median: 471.3
Gonorrhea
113.3
per 100K • 4,098 cases
-17.5 from 2022
US median: 152.2
Syphilis P&S
7.3
per 100K • 265 cases
7.4 from 2022
US median: 14.8

Connecticut sits near the bottom of national STD rankings — 43rd out of 50 states in combined rate in 2023, with 485.4 cases per 100,000 people across chlamydia, gonorrhea, and syphilis. That puts it well below the national median. But low overall rankings can obscure what's actually moving, and in Connecticut, syphilis has been moving hard — up more than 630% since 2008, from a rate of 1.0 to 7.3. That's the number that doesn't fit the otherwise calm picture.

Chlamydia remains Connecticut's most common STD by volume — 13,197 cases in 2023, at a rate of 364.8 per 100,000. That's meaningfully below the national median of 471.3, and the long-run trend is essentially flat: the rate was 357.4 in 2008 and is 364.8 today. There was a spike in 2017 that pushed the rate close to 500, but it receded. The 2023 number is up 3.8% from 2022, a modest uptick after two years of decline. Nothing here suggests a worsening problem — more a disease that never went away.

Gonorrhea tells a sharper story. The rate fell from 80 per 100,000 in 2008 to a low of 58.2 in 2015, then reversed sharply — hitting 149.9 in 2021. Since then it's pulled back, dropping 17.5% in 2023 alone to 113.3, which is now below the national median of 152.2. That's the biggest single-year decline of any disease in Connecticut's recent data. Syphilis, by contrast, has gone the other direction — from effectively negligible rates in the early 2000s (0.5 per 100,000 in 2000) to 7.3 today, still below the national median of 14.8 but on a long upward arc with a 7.4% rise in 2023.

HIV diagnoses in Connecticut trended down between 2017 and 2022 — from 273 cases to 223 — though a 2020 dip to 176 likely reflects pandemic-era testing disruptions more than an actual decline. The most recent rate, 7.2 per 100,000, represents a relatively low HIV burden compared to many states, but it's not zero, and STDs like syphilis and gonorrhea that are rising can amplify HIV transmission risk. If you're in Bridgeport, New Haven, or Hartford — where STD burden in Connecticut tends to concentrate — STDTest.com can help you find a testing location near you.

STD Trends in Connecticut

Chlamydia
364.8
per 100,000 • 13,197 cases
3.8 from 2022
2.1 since 2008

Connecticut's chlamydia rate has barely moved in 15 years — 357.4 per 100,000 in 2008, 364.8 in 2023. That long-run flatness is unusual; most states saw sharper rises. The rate sits 23% below the national median of 471.3, and while there was a notable spike to 496.7 in 2017, the trend since then has been a gradual retreat back toward the baseline.

Gonorrhea
113.3
per 100,000 • 4,098 cases
-17.5 from 2022
41.6 since 2008

Gonorrhea in Connecticut has been on a long climb — up 41.6% since 2008 — but 2023 brought the sharpest single-year reversal in recent memory, with the rate falling 17.5% to 113.3 per 100,000. That drop pushed the state back below the national median of 152.2 for the first time since 2019. Whether this represents a sustained decline or a temporary correction remains to be seen.

Syphilis (P&S)
7.3
per 100,000 • 265 cases
7.4 from 2022
630 since 2008

Syphilis is Connecticut's most striking long-run trend: a 630% increase since 2008, from a rate of 1.0 to 7.3 per 100,000. Even so, the state remains well below the national median of 14.8 — roughly half. The rate ticked up 7.4% in 2023 after a dip in 2022, suggesting the upward pressure hasn't fully resolved.

HIV
7.2
per 100,000 • 223 cases

Connecticut's HIV diagnosis rate fell from 8.9 per 100,000 in 2017 to 7.2 in 2022 — the most recent year with available data. The 2020 figure of 5.7 almost certainly reflects reduced testing access during the pandemic rather than a true drop in transmission. Since 2021, rates have stabilized in the 7-to-8 range.

Know your status — get tested today

Same-day testing at 4,500+ locations. No appointment needed. Results in 1–3 days.

Connecticut vs National Average

Comparing 2023 rates against the U.S. median across all 50 states.

Infection Connecticut US Median Difference
Chlamydia 364.8 471.3 22.6% below
Gonorrhea 113.3 152.2 25.6% below
Syphilis (P&S) 7.3 14.8 50.7% below

What the numbers mean — and what to do about them

Connecticut's combined STD rate of 485.4 per 100,000 sounds abstract until you do the math: that's roughly 17,560 new diagnoses of chlamydia, gonorrhea, or syphilis in a single year, across a state of 3.6 million people. At a national ranking of 43rd, Connecticut is genuinely on the lower end of the spectrum — but lower burden doesn't mean no burden, and the state's syphilis trajectory over the past 15 years is a reminder that individual diseases can move sharply even when the overall picture looks calm.

The clinical reality that matters most here is asymptomatic infection. The majority of chlamydia cases — and a substantial share of gonorrhea — produce no symptoms at all. Connecticut's chlamydia rate has barely budged in 15 years, which could mean rates are genuinely controlled, or it could reflect a stable pool of undiagnosed cases cycling through the population. Syphilis, meanwhile, has gone from a near-zero disease in Connecticut to one with 265 diagnosed cases in 2023 — and syphilis can remain latent and transmissible for years without obvious signs. Gonorrhea's sharp 2023 drop is welcome, but it follows a decade of increases, and the disease's growing antibiotic resistance makes regular testing more important than ever.

If you live or work in Bridgeport, New Haven, or Hartford — or anywhere in Connecticut and are sexually active — testing once a year is a reasonable floor. If you have multiple partners, don't consistently use barrier protection, or fall into a demographic category that Connecticut's data flags as higher-risk, every three to six months is more appropriate. Connecticut's syphilis rate has risen 630% since 2008 mostly without public awareness — the people driving that number largely didn't know they were infected. STDTest.com can show you testing locations across Connecticut, including same-day options in all three major cities.

WHO SHOULD GET TESTED

Sexually active adults in Connecticut — particularly those in Bridgeport, New Haven, and Hartford, where STD rates tend to be highest. Connecticut's syphilis rate has climbed 630% since 2008, with cases concentrated in urban areas and among men who have sex with men, though heterosexual transmission is also rising. Anyone with a new or multiple partners should not assume low statewide ranking means low personal risk.

HOW OFTEN

Once a year is the minimum for sexually active adults. Given that Connecticut's syphilis rate rose again in 2023 and gonorrhea remains 41% above its 2008 baseline despite a recent dip, those with multiple partners or inconsistent condom use should test every three to six months. Annual testing for HIV is also appropriate for most sexually active adults.

WHAT TO EXPECT

Most STD tests involve a urine sample, a blood draw, or a swab — often all three in a standard panel. Results typically come back within a few days. Many locations in Connecticut offer confidential or anonymous testing, and treatment for chlamydia, gonorrhea, and syphilis is straightforward when caught early. The hardest part is usually making the appointment.

Find a clinic near you

4,500+ testing locations nationwide. 100% confidential. Most insurance accepted.

FAQs

Connecticut's syphilis rate climbed from 1.0 per 100,000 in 2008 to 7.3 in 2023 — a 630% increase over 15 years. This mirrors a national pattern driven largely by rising rates among men who have sex with men and, more recently, increases in heterosexual transmission and congenital syphilis. The state still sits below the national median of 14.8, but the long-run direction is clearly upward.
Connecticut ranked 43rd out of 50 states in combined STD rate in 2023, with 485.4 cases per 100,000 people across chlamydia, gonorrhea, and syphilis. That puts it about 24% below the national combined median. Its chlamydia rate (364.8) and gonorrhea rate (113.3) both fall below their respective national medians, though syphilis continues to climb.
The 17.5% drop in Connecticut's gonorrhea rate from 2022 to 2023 — from 137.3 to 113.3 per 100,000 — is the largest single-year decline for any disease in the state's recent data. It follows a peak of 149.9 in 2021. Whether this is the start of a sustained decline or a fluctuation within a longer upward trend isn't clear yet; the rate is still 41.6% higher than it was in 2008.
STD burden in Connecticut tends to be highest in its urban centers — Bridgeport, New Haven, and Hartford. STDTest.com lists testing locations across all three cities, including options for same-day and confidential testing. You can search by zip code to find the closest available site.
Annual testing is a reasonable baseline for sexually active adults in Connecticut, given that chlamydia and gonorrhea are often asymptomatic — meaning you can carry and transmit an infection without knowing it. Given Connecticut's rising syphilis rate and the concentration of cases in cities like Hartford, New Haven, and Bridgeport, more frequent testing (every 3 to 6 months) makes sense if you have multiple partners or don't consistently use condoms.
Data sourced from the CDC's annual STI Surveillance Report. Rates are per 100,000 population and reflect reported cases only — actual prevalence is likely higher due to undiagnosed infections. While we strive for accuracy, STDTest.com makes no representations or warranties regarding the completeness or accuracy of this data and is not responsible for any errors or omissions. This page is for informational purposes only and does not constitute medical advice.